{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:55:30Z","timestamp":1789624530715,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11255-018-1930-x","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T01:47:57Z","timestamp":1531446477000},"page":"2043-2048","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The diagnostic value of human epididymis protein 4 as a novel biomarker in patients with renal dysfunction"],"prefix":"10.1007","volume":"50","author":[{"given":"Lunshan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"issue":"2","key":"1930_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0378-1119(99)00342-X","volume":"238","author":"M Schummer","year":"1999","unstructured":"Schummer M, Ng WV, Bumgarner RE et al (1999) Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene 238(2):375\u2013385","journal-title":"Gene"},{"issue":"11","key":"1930_CR2","doi-asserted-by":"publisher","first-page":"e47672","DOI":"10.1371\/journal.pone.0047672","volume":"7","author":"N Chhikara","year":"2012","unstructured":"Chhikara N, Saraswat M, Tomar AK et al (2012) Human epididymis protein-4 (HE4): a novel cross-class protease inhibitor. PLoS ONE 7(11):e47672","journal-title":"PLoS ONE"},{"key":"1930_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/1471-2407-13-423","volume":"13","author":"D da Rocha Pitta","year":"2013","unstructured":"da Rocha Pitta D, Sarian LO, Barreta A et al (2013) Symptoms,CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses. BMC Cancer 13:423","journal-title":"BMC Cancer"},{"key":"1930_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.cca.2016.06.010","volume":"459","author":"L Li","year":"2016","unstructured":"Li L, Wan J, Cai G et al (2016) Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China. Clin Chim Acta 459:170\u2013176","journal-title":"Clin Chim Acta"},{"key":"1930_CR5","first-page":"957","volume":"6","author":"ZJ Yang","year":"2013","unstructured":"Yang ZJ, Wei CY, Luo ZQ et al (2013) Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis. Onco Targets Ther 6:957\u2013966","journal-title":"Onco Targets Ther"},{"issue":"1","key":"1930_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3892\/ol.2013.1339","volume":"6","author":"Z Yang","year":"2013","unstructured":"Yang Z, Luo Z, Zhao B et al (2013) Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer. Oncol Lett 6(1):28\u201334","journal-title":"Oncol Lett"},{"issue":"2","key":"1930_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajog.2013.04.014","volume":"209","author":"SK Saarelainen","year":"2013","unstructured":"Saarelainen SK, Peltonen N, Lehtimaki T et al (2013) Predictive value of serum human epididymis protein 4 andcancer antigen 125 concentrations in endometrial carcinoma. Am J Obstet Gynecol 209(2):141\u2013146","journal-title":"Am J Obstet Gynecol"},{"key":"1930_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1258\/acb.2011.011258","volume":"49","author":"B Nagy Jr","year":"2012","unstructured":"Nagy B Jr, Krasznai ZT, Balla H et al (2012) Elevated human epididymis protein 4 concentrations in chronic kidney disease. Ann Clin Biochem 49:377\u2013380","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"1930_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nm.2989","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu VS, Teng Y, O\u2019Connell JT et al (2013) Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med 19(2):227\u2013231","journal-title":"Nat Med"},{"issue":"3","key":"1930_CR10","first-page":"124","volume":"9","author":"SJ Allison","year":"2013","unstructured":"Allison SJ (2013) Fibrosis: HE4\u2014a biomarker and target in renal fibrosis. Nat Rev Nephro 9(3):124","journal-title":"Nat Rev Nephro"},{"issue":"11","key":"1930_CR11","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1093\/ndt\/gft247","volume":"28","author":"JA Lindquist","year":"2013","unstructured":"Lindquist JA, Mertens PR (2013) Myofibroblasts, regeneration or renal fibrosis-is there a decisive hint? Nephrol Dial Transplant 28(11):2678\u20132681","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1930_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1515\/cclm-2013-0660","volume":"52","author":"S Gizzo","year":"2014","unstructured":"Gizzo S, Ancona E, Saccardi C et al (2014) Could kidney glomerularfiltration impairment represent the \u201cAchilles heel\u201d of HE4 serum marker? A possible further implication. Clin Chem Lab Med 52(3):45\u201346","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"1930_CR13","first-page":"461","volume":"30","author":"WU Ping","year":"2015","unstructured":"Ping WU, Weimin YE, Chen LI et al (2015) Research on the diagnosis significance of human epididymis protein 4 for chronic kindey disease. Lab Med 30(5):461\u2013464","journal-title":"Lab Med"},{"issue":"5","key":"1930_CR14","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1046\/j.1523-1755.2002.00299.x","volume":"61","author":"CY Hsu","year":"2002","unstructured":"Hsu CY, Chertow GM, Curhan GC (2002) Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 61(5):1567\u20131576","journal-title":"Kidney Int"},{"issue":"4","key":"1930_CR15","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1373\/clinchem.2011.167494","volume":"58","author":"MA Ferguson","year":"2012","unstructured":"Ferguson MA, Waikar SS (2012) Established and emerging markers of kidney function. Clin Chem 58(4):680\u2013689","journal-title":"Clin Chem"},{"issue":"1","key":"1930_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N, KDIGO AKI Guideline Work Group (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary. Crit Care 17(1):204","journal-title":"Crit Care"},{"issue":"11","key":"1930_CR17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A, Kidney Disease:Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825\u2013830","journal-title":"Ann Intern Med"},{"key":"1930_CR18","unstructured":"Ministry of Health of the People \u2018s Republic of China. WS\/T403-2012. analytical quality specifications for routine analytes in clinical biochemistry. China Zhijian Publishing house\/Standards Press of China, Beijing, 1\u20136 (2009)"},{"issue":"2","key":"1930_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jchf.2012.11.005","volume":"1","author":"RA de Boer","year":"2013","unstructured":"de Boer RA, Cao Q, Postmus D et al (2013) The WAP four-disulfide core domain protein HE4: a novel biomarker for heart failure. JACC Heart Fail 1(2):164\u2013169","journal-title":"JACC Heart Fail"},{"issue":"1","key":"1930_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cardfail.2016.05.002","volume":"23","author":"A Piek","year":"2017","unstructured":"Piek A, Meijers WC, Schroten NF et al (2017) HE4 serum levels are associated with heart failure severity in patients with chronic heart failure. J Card Fail 23(1):12\u201319","journal-title":"J Card Fail"},{"issue":"42","key":"1930_CR21","doi-asserted-by":"publisher","first-page":"67748","DOI":"10.18632\/oncotarget.11682","volume":"7","author":"JX Wan","year":"2016","unstructured":"Wan JX, Wang YH, Cai GR et al (2016) Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease. Oncotarget 7(42):67748\u201367759","journal-title":"Oncotarget"},{"issue":"12","key":"1930_CR22","first-page":"1376","volume":"32","author":"X-z Hu","year":"2009","unstructured":"Hu X-z, Cui L-y, Zhang J (2009) Investigation on reference range of human serum levels of human epididymis protein 4 in healthy people. China J Lab Med 32(12):1376\u20131378","journal-title":"China J Lab Med"},{"issue":"5","key":"1930_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40618-015-0402-8","volume":"39","author":"M Simeoni","year":"2016","unstructured":"Simeoni M, Cerantonio A, Pastore I et al (2016) The correct renal function evaluation in patients with thyroid dysfunction. J Endocrinol Invest 39(5):495\u2013507","journal-title":"J Endocrinol Invest"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-018-1930-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1930-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1930-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T13:07:40Z","timestamp":1588252060000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-018-1930-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1930"],"URL":"https:\/\/doi.org\/10.1007\/s11255-018-1930-x","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,13]]},"assertion":[{"value":"26 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institution and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}